• Return to Headlines

Coherus Bioscien Up 36.7% Since SmarTrend Uptrend Call (CHRS)

By Nick Russo

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 12th, 2018 at $11.96. In approximately 3 months, Coherus Bioscien has returned 36.71% as of today's recent price of $16.35.

In the past 52 weeks, Coherus Bioscien share prices have been bracketed by a low of $8.05 and a high of $17.05 and are now at $16.35, 103% above that low price. The 200-day and 50-day moving averages have moved 0.31% higher and 2.19% higher over the past week, respectively.

Coherus Biosciences, Inc. is a biopharmaceutical company. The Company develops biosimilar therapeutics to aid patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Coherus Bioscien shares.

Log in and add Coherus Bioscien (CHRS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights coherus bioscien

Ticker(s): CHRS